Research Article
The involvement of ErbB4 with schizophrenia: Association and expression studies*
*
This study was presented at the Personalized Medicine Europe workshop in Tel Aviv, Israel on June 20, 2005, and at the World Congress on Psychiatric Genetics XIII in Boston, MA on October 17, 2005.
Abstract
Neuregulin 1 (NRG1) has been found to be associated with schizophrenia in several populations. Consistently, mutant mice heterozygous for either NRG1 or its receptor, ErbB4, show a behavioral phenotype that overlaps with mouse models for schizophrenia. These observations raised the hypothesis that impaired NRG1–ErbB4 signaling may contribute to schizophrenia susceptibility. Nineteen SNPs encompassing the ErbB4 gene were selected from the HapMap database and genotyped in genomic DNA isolated from 59 Ashkenazi schizophrenia patients and 130 matched controls. Expression analysis of ErbB4 splice variants was performed on postmortem DLPFC samples obtained from Caucasian patients and controls by real‐time PCR. We found a highly significant difference between patient and control groups in three SNPs from one linkage disequilibrium (LD) block both in allele (P = 0.013, 0.0045, 0.0049) and genotype frequencies (P = 0.00013, 0.000021, 0.00018), as well as a risk haplotype (P = 0.00044). Expression analysis indicated that the CYT‐1 isoform is overexpressed in patients (P = 0.047) and that juxtamembrane (JM)‐a displays a similar trend (P = 0.081). This study provides a direct link between ErbB4 and the disease. We propose that NRG1 and its receptor ErbB4 are components of a biological pathway, involved in the pathophysiology of schizophrenia. © 2006 Wiley‐Liss, Inc.
Citing Literature
Number of times cited: 131
- Fernando J. Sialana, An-Li Wang, Benedetta Fazari, Martina Kristofova, Roman Smidak, Svenja V. Trossbach, Carsten Korth, Joseph P. Huston, Maria A. de Souza Silva and Gert Lubec, Quantitative Proteomics of Synaptosomal Fractions in a Rat Overexpressing Human DISC1 Gene Indicates Profound Synaptic Dysregulation in the Dorsal Striatum, Frontiers in Molecular Neuroscience, 11, (2018).
- Martijn Selten, Hans van Bokhoven and Nael Nadif Kasri, Inhibitory control of the excitatory/inhibitory balance in psychiatric disorders, F1000Research, 10.12688/f1000research.12155.1, 7, (23), (2018).
- Hagar Tadmor, Idit Golani, Ravid Doron, Ilana Kremer and Alon Shamir, ErbB signaling antagonist ameliorates behavioral deficit induced by phencyclidine (PCP) in mice, without affecting metabolic syndrome markers, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 82, (322), (2018).
- E. Marchisella, R. Wijnands, B. Koopmans, S. Spijker and M. Loos, Constitutive loss and acute pharmacological manipulation of ErbB4 signaling do not affect attention and inhibitory control in mice, Genes, Brain and Behavior, 17, 1, (56-69), (2017).
- Michael C Wehr, Wilko Hinrichs, Magdalena M Brzózka, Tilmann Unterbarnscheidt, Alexander Herholt, Jan P Wintgens, Sergi Papiol, Maria Clara Soto‐Bernardini, Mykola Kravchenko, Mingyue Zhang, Klaus‐Armin Nave, Sven P Wichert, Peter Falkai, Weiqi Zhang, Markus H Schwab and Moritz J Rossner, Spironolactone is an antagonist of NRG1‐ERBB4 signaling and schizophrenia‐relevant endophenotypes in mice, EMBO Molecular Medicine, 9, 10, (1448-1462), (2017).
- Chrysoula Zouraraki, Penny Karamaouna, Leda Karagiannopoulou and Stella G Giakoumaki, Schizotypy-Independent and Schizotypy-Modulated Cognitive Impairments in Unaffected First-Degree Relatives of Schizophrenia-spectrum Patients, Archives of Clinical Neuropsychology, 32, 8, (1010), (2017).
- Szabolcs Kéri, Csilla Szabó and Oguz Kelemen, Uniting the neurodevelopmental and immunological hypotheses: Neuregulin 1 receptor ErbB and Toll-like receptor activation in first-episode schizophrenia, Scientific Reports, 7, 1, (2017).
- Y.N. Dong, H. Lin, A. Rattelle, J. Panzer and D.R. Lynch, Excitotoxicity ☆, Reference Module in Biomedical Sciences, 10.1016/B978-0-12-801238-3.65836-1, (2017).
- David Feifel and Paul D. Shilling, Modeling Schizophrenia in Animals, Animal Models for the Study of Human Disease, 10.1016/B978-0-12-809468-6.00023-1, (587-617), (2017).
- Maria Auxiliadora Brasil Sampaio Cardoso, Tárcia Januário do Nascimento, Gabriel Pereira Bernardo, Lorena Pereira Bernardo, Maria Mirelle Ferreira Leite Barbosa, Pedro Januário Nascimento Neto, Danilo Ferreira de Sousa, Antonio Gilvan Teixeira Júnior, Marcos Antonio Pereira de Lima, Marcial Moreno Moreira, David de Sousa Gregório, Lídia Coelho do Nascimento Santos and Modesto Leite Rolim Neto, Are There Schizophrenia Genetic Markers and Mutations? A Systematic Review and Meta-Analyses, Health, 10.4236/health.2017.95058, 09, 05, (811-838), (2017).
- Silvia Schneider, Katja Götz, Carmen Birchmeier, Herbert Schwegler and Thomas Roskoden, Neuregulin-1 mutant mice indicate motor and sensory deficits, indeed few references for schizophrenia endophenotype model, Behavioural Brain Research, 322, (177), (2017).
- L Yan, A Shamir, M Skirzewski, E Leiva-Salcedo, O B Kwon, I Karavanova, D Paredes, O Malkesman, K R Bailey, D Vullhorst, J N Crawley and A Buonanno, Neuregulin-2 ablation results in dopamine dysregulation and severe behavioral phenotypes relevant to psychiatric disorders, Molecular Psychiatry, (2017).
- Hideki Tamura, Sadao Shiosaka and Shota Morikawa, Trophic modulation of gamma oscillations: The key role of processing protease for Neuregulin-1 and BDNF precursors, Neurochemistry International, 10.1016/j.neuint.2017.12.002, (2017).
- Simin Rahimi-Aliabadi, Neda Shahmohammadibeni, Javad Jamshidi, Ehsan Esmaili Shandiz, Reza Mirfakhraie, Mina Ohadi, Farhad Ramezani Nejad, Nader Mansoori, Mohammad Taheri, Fatemeh Gholipour, Susan Moudi, Gouya Tayebi, Shahram Divsalar, Hossein Darvish and Abolfazl Movafagh, Association of β-Secretase Functional Polymorphism with Risk of Schizophrenia, Genetic Testing and Molecular Biomarkers, 21, 4, (248), (2017).
- Yanguo Feng, Dejun Cheng, Chaofeng Zhang, Yuchun Li, Zhiying Zhang, Juan Wang and Xiao Feng, Association between ErbB4 single nucleotide polymorphisms and susceptibility to schizophrenia, Medicine, 10.1097/MD.0000000000005920, 96, 8, (e5920), (2017).
- Renata Batista-Brito, Martin Vinck, Katie A. Ferguson, Jeremy T. Chang, David Laubender, Gyorgy Lur, James M. Mossner, Victoria G. Hernandez, Charu Ramakrishnan, Karl Deisseroth, Michael J. Higley and Jessica A. Cardin, Developmental Dysfunction of VIP Interneurons Impairs Cortical Circuits, Neuron, 95, 4, (884), (2017).
- Larissa Erben, Ming-Xiao He, Annelies Laeremans, Emily Park and Andres Buonanno, A Novel Ultrasensitive In Situ Hybridization Approach to Detect Short Sequences and Splice Variants with Cellular Resolution, Molecular Neurobiology, (2017).
- Alicia K. Smith, Tanja Jovanovic, Varun Kilaru, Adriana Lori, Lauren Gensler, Samuel S. Lee, Seth Davin Norrholm, Nicholas Massa, Bruce Cuthbert, Bekh Bradley, Kerry J. Ressler and Erica Duncan, A Gene-Based Analysis of Acoustic Startle Latency, Frontiers in Psychiatry, 8, (2017).
- Gohar Fakhfouri, Jivan Khlghatyan, Ilya Sukhanov, Raul R. Gainetdinov and Jean-Martin Beaulieu, Dimensions of GSK3 Monoamine-Related Intracellular Signaling in Schizophrenia, Modeling the Psychopathological Dimensions of Schizophrenia - From Molecules to Behavior, 10.1016/B978-0-12-800981-9.00026-2, (447-462), (2016).
- Walden E. Bjørn-Yoshimoto and Suzanne M. Underhill, The importance of the excitatory amino acid transporter 3 (EAAT3), Neurochemistry International, 10.1016/j.neuint.2016.05.007, 98, (4-18), (2016).
- David A. Lewis and Jill R. Glausier, Alterations in Prefrontal Cortical Circuitry and Cognitive Dysfunction in Schizophrenia, The Neuropsychopathology of Schizophrenia, 10.1007/978-3-319-30596-7_3, (31-75), (2016).
- Tiffany A. Greenwood, Laura C. Lazzeroni, Monica E. Calkins, Robert Freedman, Michael F. Green, Raquel E. Gur, Ruben C. Gur, Gregory A. Light, Keith H. Nuechterlein, Ann Olincy, Allen D. Radant, Larry J. Seidman, Larry J. Siever, Jeremy M. Silverman, William S. Stone, Catherine A. Sugar, Neal R. Swerdlow, Debby W. Tsuang, Ming T. Tsuang, Bruce I. Turetsky and David L. Braff, Genetic assessment of additional endophenotypes from the Consortium on the Genetics of Schizophrenia Family Study, Schizophrenia Research, 170, 1, (30), (2016).
- Chenyao Wang, Branko Aleksic and Norio Ozaki, Glia‐related genes and their contribution to schizophrenia, Psychiatry and Clinical Neurosciences, 69, 8, (448-461), (2015).
- Vanessa Douet, Linda Chang, Kristin Lee and Thomas Ernst, ERBB4 polymorphism and family history of psychiatric disorders on age-related cortical changes in healthy children, Brain Imaging and Behavior, 10.1007/s11682-015-9363-y, 9, 1, (128-140), (2015).
- Ajay Jajodia, Harpreet Kaur, Kalpana Kumari, Meenal Gupta, Ruchi Baghel, Ankit Srivastava, Mamta Sood, Rakesh Kumar Chadda, Sanjeev Jain and Ritushree Kukreti, Evidence for schizophrenia susceptibility alleles in the Indian population: An association of neurodevelopmental genes in case–control and familial samples, Schizophrenia Research, 162, 1-3, (112), (2015).
- Tomoyasu Wakuda, Keiko Iwata, Yasuhide Iwata, Ayyappan Anitha, Taro Takahashi, Kohei Yamada, Mahesh Mundalil Vasu, Hideo Matsuzaki, Katsuaki Suzuki and Norio Mori, Perinatal asphyxia alters neuregulin-1 and COMT gene expression in the medial prefrontal cortex in rats, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 56, (149), (2015).
- Saurav Seshadri, Travis Faust, Koko Ishizuka, Kristen Delevich, Youjin Chung, Sun-Hong Kim, Martis Cowles, Minae Niwa, Hanna Jaaro-Peled, Toshifumi Tomoda, Cary Lai, E. S. Anton, Bo Li and Akira Sawa, Interneuronal DISC1 regulates NRG1-ErbB4 signalling and excitatory–inhibitory synapse formation in the mature cortex, Nature Communications, 6, 1, (2015).
- D-M Yin, Y-J Chen, S Liu, H Jiao, C Shen, A Sathyamurthy, T W Lin, W-C Xiong, B-M Li, L Mei and C Bergson, Calcyon stimulates neuregulin 1 maturation and signaling, Molecular Psychiatry, 10.1038/mp.2014.131, 20, 10, (1251-1260), (2014).
- Kazue Muraki and Kenji Tanigaki, Neuronal migration abnormalities and its possible implications for schizophrenia, Frontiers in Neuroscience, 9, (2015).
- Chao Deng, Bo Pan, Chang-Hua Hu, Mei Han and Xu-Feng Huang, Differential effects of short- and long-term antipsychotic treatment on the expression of neuregulin-1 and ErbB4 receptors in the rat brain, Psychiatry Research, 10.1016/j.psychres.2014.12.014, 225, 3, (347-354), (2015).
- Ann M. Hemmerle, Rebecca Ahlbrand, Stefanie L. Bronson, Kerstin H. Lundgren, Neil M. Richtand and Kim B. Seroogy, Modulation of schizophrenia-related genes in the forebrain of adolescent and adult rats exposed to maternal immune activation, Schizophrenia Research, 10.1016/j.schres.2015.07.006, 168, 1-2, (411-420), (2015).
- Margaret A. Cooper and Anthony J. Koleske, Ablation of ErbB4 from excitatory neurons leads to reduced dendritic spine density in mouse prefrontal cortex, Journal of Comparative Neurology, 522, 14, (3351-3362), (2014).
- R Fine, J Zhang and H E Stevens, Prenatal stress and inhibitory neuron systems: implications for neuropsychiatric disorders, Molecular Psychiatry, 10.1038/mp.2014.35, 19, 6, (641-651), (2014).
- Catherine L. Winchester, Judith A. Pratt and Brian J. Morris, Risk genes for schizophrenia: Translational opportunities for drug discovery, Pharmacology & Therapeutics, 10.1016/j.pharmthera.2014.02.003, 143, 1, (34-50), (2014).
- Xiongjian Luo, Liang Huang, Leng Han, Zhenwu Luo, Fang Hu, Roger Tieu and Lin Gan, Systematic Prioritization and Integrative Analysis of Copy Number Variations in Schizophrenia Reveal Key Schizophrenia Susceptibility Genes, Schizophrenia Bulletin, 10.1093/schbul/sbu045, 40, 6, (1285-1299), (2014).
- Dipesh Joshi, Janice M. Fullerton and Cynthia Shannon Weickert, Elevated ErbB4 mRNA is related to interneuron deficit in prefrontal cortex in schizophrenia, Journal of Psychiatric Research, 10.1016/j.jpsychires.2014.02.014, 53, (125-132), (2014).
- Anu Loukola, Jenni Hällfors, Tellervo Korhonen and Jaakko Kaprio, Genetics and Smoking, Current Addiction Reports, 10.1007/s40429-013-0006-3, 1, 1, (75-82), (2014).
- Jingrui Xing, Chenyao Wang, Hiroki Kimura, Yuto Takasaki, Shohko Kunimoto, Akira Yoshimi, Yukako Nakamura, Takayoshi Koide, Masahiro Banno, Itaru Kushima, Yota Uno, Takashi Okada, Branko Aleksic, Masashi Ikeda, Nakao Iwata, Norio Ozaki and Namik Kaya, Resequencing and Association Analysis of PTPRA, a Possible Susceptibility Gene for Schizophrenia and Autism Spectrum Disorders, PLoS ONE, 9, 11, (e112531), (2014).
- Amanda J. Law, NRG1/ErbB4 and the PI3K/AKT pathway: Novel therapeutic options for schizophrenia, Schizophrenia Research, 160, 1-3, (e10), (2014).
- Federica Fregnan, Sara Gnavi, Loredana Macrì, Isabelle Perroteau and Giovanna Gambarotta, The four isoforms of the tyrosine kinase receptor ErbB4 provide neural progenitor cells with an adhesion preference for the transmembrane type III isoform of the ligand neuregulin 1, NeuroReport, 25, 4, (233), (2014).
- Sarah Tosato, Martina Zanoni, Chiara Bonetto, Federica Tozzi, Clyde Francks, Elisa Ira, Simona Tomassi, Mariaelena Bertani, Dan Rujescu, Ina Giegling, David St Clair, Michele Tansella, Mirella Ruggeri and Pierandrea Muglia, No Association Between NRG1 and ErbB4 Genes and Psychopathological Symptoms of Schizophrenia, NeuroMolecular Medicine, 10.1007/s12017-014-8323-9, 16, 4, (742-751), (2014).
- A Loukola, J Wedenoja, K Keskitalo-Vuokko, U Broms, T Korhonen, S Ripatti, A-P Sarin, J Pitkäniemi, L He, A Häppölä, K Heikkilä, Y-L Chou, M L Pergadia, A C Heath, G W Montgomery, N G Martin, P A F Madden and J Kaprio, Genome-wide association study on detailed profiles of smoking behavior and nicotine dependence in a twin sample, Molecular Psychiatry, 10.1038/mp.2013.72, 19, 5, (615-624), (2013).
- Peter Penzes, Christine Remmers, Michael E. Cahill, Kelly A. Jones, Jon-Eric VanLeeuwen and Kevin M. Woolfrey, Structural Alterations of Synapses in Psychiatric and Neurodegenerative Disorders, The Synapse, 10.1016/B978-0-12-418675-0.00009-2, (281-300), (2014).
- David A Lewis, Inhibitory neurons in human cortical circuits: substrate for cognitive dysfunction in schizophrenia, Current Opinion in Neurobiology, 26, (22), (2014).
- Lin Mei and Klaus-Armin Nave, Neuregulin-ERBB Signaling in the Nervous System and Neuropsychiatric Diseases, Neuron, 10.1016/j.neuron.2014.06.007, 83, 1, (27-49), (2014).
- Kim B. Seroogy, Jonathan W. Dickerson, Sarah N. Cassella and Lixin Zhang-Auberson, Neuregulins, Handbook of Biologically Active Peptides, 10.1016/B978-0-12-385095-9.00223-2, (1633-1638), (2013).
- Nagahide Takahashi and Takeshi Sakurai, Roles of glial cells in schizophrenia: Possible targets for therapeutic approaches, Neurobiology of Disease, 10.1016/j.nbd.2012.11.001, 53, (49-60), (2013).
- Isabel del Pino, Cristina García-Frigola, Nathalie Dehorter, Jorge R. Brotons-Mas, Efrén Alvarez-Salvado, María Martínez de Lagrán, Gabriele Ciceri, María Victoria Gabaldón, David Moratal, Mara Dierssen, Santiago Canals, Oscar Marín and Beatriz Rico, Erbb4 Deletion from Fast-Spiking Interneurons Causes Schizophrenia-like Phenotypes, Neuron, 10.1016/j.neuron.2013.07.010, 79, 6, (1152-1168), (2013).
- Chao Deng, Bo Pan, Martin Engel and Xu-Feng Huang, Neuregulin-1 signalling and antipsychotic treatment, Psychopharmacology, 226, 2, (201), (2013).
- Saurav Seshadri, Mariela Zeledon and Akira Sawa, Synapse-specific contributions in the cortical pathology of schizophrenia, Neurobiology of Disease, 10.1016/j.nbd.2013.01.009, 53, (26-35), (2013).
- Emma Sprooten, Kathryn M. Fleming, Pippa A. Thomson, Mark E. Bastin, Heather C. Whalley, Jeremy Hall, Jess E. Sussmann, James McKirdy, Douglas Blackwood, Stephen M. Lawrie and Andrew M. McIntosh, White matter integrity as an intermediate phenotype: Exploratory genome-wide association analysis in individuals at high risk of bipolar disorder, Psychiatry Research, 10.1016/j.psychres.2012.11.002, 206, 2-3, (223-231), (2013).
- A Hatzimanolis, J A McGrath, R Wang, T Li, P C Wong, G Nestadt, P S Wolyniec, D Valle, A E Pulver and D Avramopoulos, Multiple variants aggregate in the neuregulin signaling pathway in a subset of schizophrenia patients, Translational Psychiatry, 10.1038/tp.2013.33, 3, 5, (e264), (2013).
- David Feifel and Paul D. Shilling, Modeling Schizophrenia in Animals, Animal Models for the Study of Human Disease, 10.1016/B978-0-12-415894-8.00030-0, (727-755), (2013).
- Nicholas C. Stefanis, Alex Hatzimanolis, Nikolaos Smyrnis, Dimitrios Avramopoulos, Ioannis Evdokimidis, Jim van Os, Costas N. Stefanis, Richard E. Straub and Daniel R. Weinberger, Schizophrenia Candidate Gene ERBB4: Covert Routes of Vulnerability to Psychosis Detected at the Population Level, Schizophrenia Bulletin, 10.1093/schbul/sbr169, 39, 2, (349-357), (2011).
- Melis Inan, Timothy J. Petros and Stewart A. Anderson, Losing your inhibition: Linking cortical GABAergic interneurons to schizophrenia, Neurobiology of Disease, 10.1016/j.nbd.2012.11.013, 53, (36-48), (2013).
- M Mizuno, H Sotoyama, H Namba, M Shibuya, T Eda, R Wang, T Okubo, K Nagata, Y Iwakura and H Nawa, ErbB inhibitors ameliorate behavioral impairments of an animal model for schizophrenia: implication of their dopamine-modulatory actions, Translational Psychiatry, 3, 4, (e252), (2013).
- Omid Kohannim, Neda Jahanshad, Meredith N Braskie, Jason L Stein, Ming-Chang Chiang, April H Reese, Derrek P Hibar, Arthur W Toga, Katie L McMahon, Greig I de Zubicaray, Sarah E Medland, Grant W Montgomery, Nicholas G Martin, Margaret J Wright and Paul M Thompson, Predicting White Matter Integrity from Multiple Common Genetic Variants, Neuropsychopharmacology, 37, 9, (2012), (2012).
- Ilkka Paatero, Anne Jokilammi, Pekka T. Heikkinen, Kristiina Iljin, Olli-Pekka Kallioniemi, Frank E. Jones, Panu M. Jaakkola and Klaus Elenius, Interaction with ErbB4 Promotes Hypoxia-inducible Factor-1α Signaling, Journal of Biological Chemistry, 10.1074/jbc.M111.299537, 287, 13, (9659-9671), (2012).
- M. Kvajo, H. McKellar and J.A. Gogos, Avoiding mouse traps in schizophrenia genetics: lessons and promises from current and emerging mouse models, Neuroscience, 211, (136), (2012).
- Beatriz Rico, Finding a druggable target for schizophrenia: Fig. 1., Proceedings of the National Academy of Sciences, 10.1073/pnas.1209389109, 109, 30, (11902-11903), (2012).
- C S Weickert, Y Tiwari, P R Schofield, B J Mowry and J M Fullerton, Schizophrenia-associated HapICE haplotype is associated with increased NRG1 type III expression and high nucleotide diversity, Translational Psychiatry, 10.1038/tp.2012.25, 2, 4, (e104), (2012).
- Ori S. Cohen, Sarah Y. Mccoy, Frank A. Middleton, Sean Bialosuknia, Yanli Zhang-James, Lu Liu, Ming T. Tsuang, Stephen V. Faraone and Stephen J. Glatt, Transcriptomic analysis of postmortem brain identifies dysregulated splicing events in novel candidate genes for schizophrenia, Schizophrenia Research, 142, 1-3, (188), (2012).
- Clare Faux, Sonja Rakic, William Andrews and Joanne M. Britto, Neurons on the Move: Migration and Lamination of Cortical Interneurons, Neurosignals, 20, 3, (168), (2012).
- M E Cahill, K A Jones, I Rafalovich, Z Xie, C S Barros, U Müller and P Penzes, Control of interneuron dendritic growth through NRG1/erbB4-mediated kalirin-7 disinhibition, Molecular Psychiatry, 17, 1, (99), (2012).
- Peng Chen, Jianhua Chen, Ke Huang, Weidong Ji, Ti Wang, Tao Li, Yang Wang, Hankun Wang, Lin He, Guoyin Feng and Yongyong Shi, Analysis of association between common SNPs in ErbB4 and bipolar affective disorder, major depressive disorder and schizophrenia in the Han Chinese population, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 10.1016/j.pnpbp.2011.09.011, 36, 1, (17-21), (2012).
- Joon Seol Bae, Charisse Flerida A. Pasaje, Byung-Lae Park, Hyun Sub Cheong, Jeong-Hyun Kim, Jason Yongha Kim, Joong-Gon Shin, Chul Soo Park, Bong-Jo Kim, Cheol-Soon Lee, Migyung Lee, Woo Hyuk Choi, Tae-Min Shin, Jaewook Hwang, Hyoung Doo Shin and Sung-Il Woo, Genetic association analysis of ERBB4 polymorphisms with the risk of schizophrenia and SPEM abnormality in a Korean population, Brain Research, 10.1016/j.brainres.2012.05.029, 1466, (146-151), (2012).
- Amanda J. Law, Yanhong Wang, Yoshitatsu Sei, Patricio O’Donnell, Patrick Piantadosi, Francesco Papaleo, Richard E. Straub, Wenwei Huang, Craig J. Thomas, Radhakrishna Vakkalanka, Aaron D. Besterman, Barbara K. Lipska, Thomas M. Hyde, Paul J. Harrison, Joel E. Kleinman and Daniel R. Weinberger, Neuregulin 1-ErbB4-PI3K signaling in schizophrenia and phosphoinositide 3-kinase-p110δ inhibition as a potential therapeutic strategy, Proceedings of the National Academy of Sciences, 109, 30, (12165), (2012).
- D M Cannon, M Walshe, E Dempster, D A Collier, N Marshall, E Bramon, R M Murray and C McDonald, The association of white matter volume in psychotic disorders with genotypic variation in NRG1, MOG and CNP: a voxel-based analysis in affected individuals and their unaffected relatives, Translational Psychiatry, 2, 10, (e167), (2012).
- Bo Pan, Xu-Feng Huang and Chao Deng, Antipsychotic treatment and neuregulin 1–ErbB4 signalling in schizophrenia, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 35, 4, (924), (2011).
- Nagahide Takahashi, Karin Sandager Nielsen, Branko Aleksic, Steffen Petersen, Masashi Ikeda, Itaru Kushima, Nathalie Vacaresse, Hiroshi Ujike, Nakao Iwata, Véronique Dubreuil, Naheed Mirza, Takeshi Sakurai, Norio Ozaki, Joseph D. Buxbaum and Jan Sap, Loss of Function Studies in Mice and Genetic Association Link Receptor Protein Tyrosine Phosphatase α to Schizophrenia, Biological Psychiatry, 10.1016/j.biopsych.2011.06.016, 70, 7, (626-635), (2011).
- Stephen J. Glatt, Ori S. Cohen, Stephen V. Faraone and Ming T. Tsuang, Dysfunctional gene splicing as a potential contributor to neuropsychiatric disorders, American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 156, 4, (382-392), (2011).
- E. Rossignol, Genetics and Function of Neocortical GABAergic Interneurons in Neurodevelopmental Disorders, Neural Plasticity, 2011, (1), (2011).
- Amy E. Geddes, Xu-Feng Huang and Kelly A. Newell, Reciprocal signalling between NR2 subunits of the NMDA receptor and neuregulin1 and their role in schizophrenia, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 10.1016/j.pnpbp.2011.02.017, 35, 4, (896-904), (2011).
- Riccardo Zuliani, T. William J. Moorhead, Mark E. Bastin, Eve C. Johnstone, Stephen M. Lawrie, Paolo Brambilla, Michael C. O'Donovan, Michael J. Owen, Jeremy Hall and Andrew M. McIntosh, Genetic variants in the ErbB4 gene are associated with white matter integrity, Psychiatry Research: Neuroimaging, 10.1016/j.pscychresns.2010.11.001, 191, 2, (133-137), (2011).
- Graham M Pitcher, Lorraine V Kalia, David Ng, Nathalie M Goodfellow, Kathleen T Yee, Evelyn K Lambe and Michael W Salter, Schizophrenia susceptibility pathway neuregulin 1–ErbB4 suppresses Src upregulation of NMDA receptors, Nature Medicine, 10.1038/nm.2315, 17, 4, (470-478), (2011).
- Jörg Neddens, Kenneth N. Fish, Ludovic Tricoire, Detlef Vullhorst, Alon Shamir, Wonjae Chung, David A. Lewis, Chris J. McBain and Andrés Buonanno, Conserved Interneuron-Specific ErbB4 Expression in Frontal Cortex of Rodents, Monkeys, and Humans: Implications for Schizophrenia, Biological Psychiatry, 70, 7, (636), (2011).
- N Takahashi, T Sakurai, O Bozdagi-Gunal, N P Dorr, J Moy, L Krug, M Gama-Sosa, G A Elder, R J Koch, R H Walker, P R Hof, K L Davis and J D Buxbaum, Increased expression of receptor phosphotyrosine phosphatase-β/ζ is associated with molecular, cellular, behavioral and cognitive schizophrenia phenotypes, Translational Psychiatry, 10.1038/tp.2011.8, 1, 5, (e8), (2011).
- Kristen J. Brennand and Fred H. Gage, Concise Review: The Promise of Human Induced Pluripotent Stem Cell‐Based Studies of Schizophrenia, STEM CELLS, 29, 12, (1915-1922), (2011).
- Brien Riley and Kenneth S. Kendler, Classical Genetic Studies of Schizophrenia, Schizophrenia, (245-268), (2011).
- Beatriz Rico and Oscar Marín, Neuregulin signaling, cortical circuitry development and schizophrenia, Current Opinion in Genetics & Development, 10.1016/j.gde.2010.12.010, 21, 3, (262-270), (2011).
- Darrick T. Balu and Joseph T. Coyle, Neuroplasticity signaling pathways linked to the pathophysiology of schizophrenia, Neuroscience & Biobehavioral Reviews, 10.1016/j.neubiorev.2010.10.005, 35, 3, (848-870), (2011).
- Ran-Sook Woo, Ji-Hye Lee, Ha-Nul Yu, Dae-Yong Song and Tai-Kyoung Baik, Expression of ErbB4 in the neurons of Alzheimer's disease brain and APP/PS1 mice, a model of Alzheimer's disease, Anatomy & Cell Biology, 44, 2, (116), (2011).
- Yu Feng, Xiao-Dong Wang, Chun-Mei Guo, Yang Yang, Ji-Tao Li, Yun-Ai Su and Tian-Mei Si, Expressions of Neuregulin 1 and ErbB4 in Prefrontal Cortex and Hippocampus of a Rat Schizophrenia Model Induced by Chronic MK-801 Administration , Journal of Biomedicine and Biotechnology, 10.1155/2010/859516, 2010, (1-7), (2010).
- Gilad Silberberg, Dorit Ben-Shachar and Ruth Navon, Genetic analysis of nitric oxide synthase 1 variants in schizophrenia and bipolar disorder, American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 153B, 7, (1318), (2010).
- Stefano Marenco and Eugenia Radulescu, Imaging genetics of structural brain connectivity and neural integrity markers, NeuroImage, 10.1016/j.neuroimage.2009.11.030, 53, 3, (848-856), (2010).
- Andrés Buonanno, The neuregulin signaling pathway and schizophrenia: From genes to synapses and neural circuits, Brain Research Bulletin, 10.1016/j.brainresbull.2010.07.012, 83, 3-4, (122-131), (2010).
- Ina Giegling, Just Genius, Jens Benninghoff and Dan Rujescu, Genetic findings in schizophrenia patients related to alterations in the intracellular Ca-homeostasis, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 10.1016/j.pnpbp.2010.06.018, 34, 8, (1375-1380), (2010).
- Anamika Banerjee, Mathew L. MacDonald, Karin E. Borgmann-Winter and Chang-Gyu Hahn, Neuregulin 1–erbB4 pathway in schizophrenia: From genes to an interactome, Brain Research Bulletin, 10.1016/j.brainresbull.2010.04.011, 83, 3-4, (132-139), (2010).
- David F. Stern, EGFs and ERBBs—Brief history and prospects, Seminars in Cell & Developmental Biology, 21, 9, (917), (2010).
- Akiko Hayashi-Takagi and Akira Sawa, Disturbed synaptic connectivity in schizophrenia: Convergence of genetic risk factors during neurodevelopment, Brain Research Bulletin, 83, 3-4, (140), (2010).
- Tomomi Morikawa and Takayuki Manabe, Aberrant regulation of alternative pre-mRNA splicing in schizophrenia, Neurochemistry International, 10.1016/j.neuint.2010.08.012, 57, 7, (691-704), (2010).
- Y.-J. Chen, M. Zhang, D.-M. Yin, L. Wen, A. Ting, P. Wang, Y.-S. Lu, X.-H. Zhu, S.-J. Li, C.-Y. Wu, X.-M. Wang, C. Lai, W.-C. Xiong, L. Mei and T.-M. Gao, ErbB4 in parvalbumin-positive interneurons is critical for neuregulin 1 regulation of long-term potentiation, Proceedings of the National Academy of Sciences, 107, 50, (21818), (2010).
- Victor Z. Chong, Mia Thompson, Senda Beltaifa, Maree J. Webster, Amanda J. Law and Cynthia Shannon Weickert, Aumento de los valores de las proteínas neurregulina 1 y ErbB4 en la corteza prefrontal de pacientes esquizofrénicos, Psiquiatría Biológica, 10.1016/j.psiq.2010.04.002, 17, 2, (54-62), (2010).
- Hon‐Cheong So, Pui Y. Fong, Ronald Y.L. Chen, Tomy C.K. Hui, Mandy Y.M. Ng, Stacey S. Cherny, William W.M. Mak, Eric F.C. Cheung, Raymond C.K. Chan, Eric Y.H. Chen, Tao Li and Pak C. Sham, Identification of neuroglycan C and interacting partners as potential susceptibility genes for schizophrenia in a Southern Chinese population, American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 153B, 1, (103-113), (2009).
- Chao-Lin Lu, Ying-Chieh Wang, Jen-Yeu Chen, I-Ching Lai and Ying-Jay Liou, Support for the involvement of the ERBB4 gene in schizophrenia: A genetic association analysis, Neuroscience Letters, 10.1016/j.neulet.2010.06.067, 481, 2, (120-125), (2010).
- L. Wen, Y.-S. Lu, X.-H. Zhu, X.-M. Li, R.-S. Woo, Y.-J. Chen, D.-M. Yin, C. Lai, A. V. Terry, A. Vazdarjanova, W.-C. Xiong and L. Mei, Neuregulin 1 regulates pyramidal neuron activity via ErbB4 in parvalbumin-positive interneurons, Proceedings of the National Academy of Sciences, 10.1073/pnas.0910302107, 107, 3, (1211-1216), (2009).
- André Fisahn, Jörg Neddens, Leqin Yan and Andrés Buonanno, Neuregulin-1 Modulates Hippocampal Gamma Oscillations: Implications for Schizophrenia, Cerebral Cortex, 10.1093/cercor/bhn107, 19, 3, (612-618), (2008).
- Andreas Konrad, Goran Vucurevic, Francesco Musso, Peter Stoeter, Norbert Dahmen and Georg Winterer, ErbB4 Genotype Predicts Left Frontotemporal Structural Connectivity in Human Brain, Neuropsychopharmacology, 10.1038/npp.2008.112, 34, 3, (641-650), (2008).
- Y. Abe, H. Namba, Y. Zheng and H. Nawa, In situ hybridization reveals developmental regulation of ErbB1-4 mRNA expression in mouse midbrain: Implication of ErbB receptors for dopaminergic neurons, Neuroscience, 10.1016/j.neuroscience.2009.03.022, 161, 1, (95-110), (2009).
- Joerg Neddens, Detlef Vullhorst and Andres Buonanno, Neuregulin links dopaminergic and glutamatergic neurotransmission to control hippocampal synaptic plasticity, Communicative & Integrative Biology, 2, 3, (261), (2009).
- Yingjun Zheng, Akiya Watakabe, Masahiko Takada, Akiyoshi Kakita, Hisaaki Namba, Hitoshi Takahashi, Tetsuo Yamamori and Hiroyuki Nawa, Expression of ErbB4 in substantia nigra dopamine neurons of monkeys and humans, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 33, 4, (701), (2009).
- Jeremy Hall, Liana Romaniuk, Andrew M. McIntosh, J. Douglas Steele, Eve C. Johnstone and Stephen M. Lawrie, Associative learning and the genetics of schizophrenia, Trends in Neurosciences, 10.1016/j.tins.2009.01.011, 32, 6, (359-365), (2009).
- Hans O. Kalkman, Altered growth factor signaling pathways as the basis of aberrant stem cell maturation in schizophrenia, Pharmacology & Therapeutics, 10.1016/j.pharmthera.2008.11.002, 121, 1, (115-122), (2009).
- Jenny Wong and Cynthia Shannon Weickert, Transcriptional Interaction of an Estrogen Receptor Splice Variant and ErbB4 Suggests Convergence in Gene Susceptibility Pathways in Schizophrenia, Journal of Biological Chemistry, 284, 28, (18824), (2009).
- N. Zeng, L. Liu, M. G. McCabe, D. T. W. Jones, K. Ichimura and V. P. Collins, Real-time quantitative polymerase chain reaction (qPCR) analysis with fluorescence resonance energy transfer (FRET) probes reveals differential expression of the fourERBB4juxtamembrane region variants between medulloblastoma and pilocytic astrocytoma, Neuropathology and Applied Neurobiology, 35, 4, (353), (2009).
- Stacey Williams, Colleen Ryan and Christian Jacobson, Agrin and neuregulin, expanding roles and implications for therapeutics, Biotechnology Advances, 26, 3, (187), (2008).
- Xiao-Dong Wang, Yun-Ai Su, Chun-Mei Guo, Yang Yang and Tian-Mei Si, Chronic antipsychotic drug administration alters the expression of neuregulin 1β, ErbB2, ErbB3, and ErbB4 in the rat prefrontal cortex and hippocampus, The International Journal of Neuropsychopharmacology, 11, 04, (2008).
- Alexis Kaushansky, Andrew Gordus, Bogdan A. Budnik, William S. Lane, John Rush and Gavin MacBeath, System-wide Investigation of ErbB4 Reveals 19 Sites of Tyr Phosphorylation that Are Unusually Selective in Their Recruitment Properties, Chemistry & Biology, 10.1016/j.chembiol.2008.07.006, 15, 8, (808-817), (2008).
- J D Buxbaum, L Georgieva, J J Young, C Plescia, Y Kajiwara, Y Jiang, V Moskvina, N Norton, T Peirce, H Williams, N J Craddock, L Carroll, G Corfas, K L Davis, M J Owen, S Harroch, T Sakurai and M C O'Donovan, Molecular dissection of NRG1-ERBB4 signaling implicates PTPRZ1 as a potential schizophrenia susceptibility gene, Molecular Psychiatry, 10.1038/sj.mp.4001991, 13, 2, (162-172), (2007).
- Victor Z. Chong, Maree J. Webster, Debora A. Rothmond and Cynthia Shannon Weickert, Specific developmental reductions in subventricular zone ErbB1 and ErbB4 mRNA in the human brain, International Journal of Developmental Neuroscience, 10.1016/j.ijdevneu.2008.06.004, 26, 7, (791-803), (2008).
- Ying-Chieh Wang, Jen-Yeu Chen, Mao-Liang Chen, Chia-Hsiang Chen, I.-Ching Lai, Tzu-Ting Chen, Chen-Jee Hong, Shih-Jen Tsai and Ying-Jay Liou, Neuregulin 3 Genetic Variations and Susceptibility to Schizophrenia in a Chinese Population, Biological Psychiatry, 64, 12, (1093), (2008).
- Yue Feng, Convergence and Divergence in the Etiology of Myelin Impairment in Psychiatric Disorders and Drug Addiction, Neurochemical Research, 10.1007/s11064-008-9693-x, 33, 10, (1940-1949), (2008).
- Graham M. Pitcher, Simon Beggs, Ran-Sook Woo, Lin Mei and Michael W. Salter, ErbB4 is a suppressor of long-term potentiation in the adult hippocampus, NeuroReport, 10.1097/WNR.0b013e3282f3da10, 19, 2, (139-143), (2008).
- Lin Mei and Wen-Cheng Xiong, Neuregulin 1 in neural development, synaptic plasticity and schizophrenia, Nature Reviews Neuroscience, 10.1038/nrn2392, 9, 6, (437-452), (2008).
- Sae Shiota, Mamoru Tochigi, Hiroko Shimada, Jun Ohashi, Kiyoto Kasai, Nobumasa Kato, Katsushi Tokunaga and Tsukasa Sasaki, Association and interaction analyses of NRG1 and ERBB4 genes with schizophrenia in a Japanese population, Journal of Human Genetics, 10.1007/s10038-008-0332-9, 53, 10, (929-935), (2008).
- Mark J. Millan and Mauricette Brocco, Cognitive Impairment in Schizophrenia: a Review of Developmental and Genetic Models, and Pro-cognitive Profile of the Optimised D3 > D2 Antagonist, S33138, Thérapie, 63, 3, (187), (2008).
- Amanda J. Law, Joel E. Kleinman, Daniel R. Weinberger and Cynthia Shannon Weickert, Disease-associated intronic variants in the ErbB4 gene are related to altered ErbB4 splice-variant expression in the brain in schizophrenia, Human Molecular Genetics, 10.1093/hmg/ddl449, 16, 2, (129-141), (2006).
- Gerald D. Fischbach, NRG1 and Synaptic Function in the CNS, Neuron, 54, 4, (495), (2007).
- Yuichiro Watanabe, Naoki Fukui, Ayako Nunokawa, Tatsuyuki Muratake, Naoshi Kaneko, Hideaki Kitamura and Toshiyuki Someya, No association between the ERBB3 gene and schizophrenia in a Japanese population, Neuroscience Research, 10.1016/j.neures.2007.01.001, 57, 4, (574-578), (2007).
- Lin Mei and Wen-Cheng Xiong, Neuregulin-1 signaling in schizophrenia, Future Neurology, 10.2217/14796708.2.5.477, 2, 5, (477-480), (2007).
- Bo Li, Ran-Sook Woo, Lin Mei and Roberto Malinow, The Neuregulin-1 Receptor ErbB4 Controls Glutamatergic Synapse Maturation and Plasticity, Neuron, 10.1016/j.neuron.2007.03.028, 54, 4, (583-597), (2007).
- M. Longart, M. Chatani-Hinze, C.M. Gonzalez, D. Vullhorst and A. Buonanno, Regulation of ErbB-4 endocytosis by neuregulin in GABAergic hippocampal interneurons, Brain Research Bulletin, 73, 4-6, (210), (2007).
- Daniel C. Javitt, Glutamate and Schizophrenia: Phencyclidine, N‐Methyl‐d‐Aspartate Receptors, and Dopamine–Glutamate Interactions, Integrating the Neurobiology of Schizophrenia, 10.1016/S0074-7742(06)78003-5, (69-108), (2007).
- N. Mechawar, B. Lacoste, W.-F. Yu, L.K. Srivastava and R. Quirion, Developmental profile of neuregulin receptor ErbB4 in postnatal rat cerebral cortex and hippocampus, Neuroscience, 10.1016/j.neuroscience.2007.04.066, 148, 1, (126-139), (2007).
- Ricardo Cáceda, Becky Kinkead and Charles B. Nemeroff, Involvement of Neuropeptide Systems in Schizophrenia: Human Studies, Integrating the Neurobiology of Schizophrenia, 10.1016/S0074-7742(06)78011-4, (327-376), (2007).
- Asif M. Maroof and Stewart A. Anderson, Off on a Tangent: Thalamocortical Axons Traverse a Permissive Corridor across the Basal Telencephalon, Neuron, 50, 2, (185), (2006).
- Carl P. Wonders and Stewart A. Anderson, The origin and specification of cortical interneurons, Nature Reviews Neuroscience, 7, 9, (687), (2006).
- Zeynep Sena Agim, Melda Esendal, Laurent Briollais, Ozgun Uyan, Mehran Meschian, Luis Antonio Mendoza Martinez, Yongmei Ding, A. Nazli Basak, Hilmi Ozcelik and Valerie W. Hu, Discovery, Validation and Characterization of Erbb4 and Nrg1 Haplotypes Using Data from Three Genome-Wide Association Studies of Schizophrenia, PLoS ONE, 10.1371/journal.pone.0053042, 8, 1, (e53042), (2013).
- Fernando S. Goes, Michael Rongione, Yun-Ching Chen, Rachel Karchin, Eran Elhaik, James B. Potash and Katharina Domschke, Exonic DNA Sequencing of ERBB4 in Bipolar Disorder, PLoS ONE, 10.1371/journal.pone.0020242, 6, 5, (e20242), (2011).
- Md Shaki Mostaid, Ting Ting Lee, Gursharan Chana, Suresh Sundram, Cynthia Shannon Weickert, Christos Pantelis, Ian Everall and Chad Bousman, Peripheral Transcription of NRG-ErbB Pathway Genes Are Upregulated in Treatment-Resistant Schizophrenia, Frontiers in Psychiatry, 10.3389/fpsyt.2017.00225, 8, (2017).
- Maha Elsayed and Pierre J. Magistretti, A New Outlook on Mental Illnesses: Glial Involvement Beyond the Glue, Frontiers in Cellular Neuroscience, 10.3389/fncel.2015.00468, 9, (2015).
